• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英夫利昔单抗成功治疗长期神经白塞病。

Successful treatment of long-standing neuro-Behçet's disease with infliximab.

作者信息

Sarwar Haroon, McGrath Hugh, Espinoza Luis R

机构信息

Section of Rheumatology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA.

出版信息

J Rheumatol. 2005 Jan;32(1):181-3.

PMID:15630746
Abstract

Behçet's disease is a chronic relapsing form of vasculitis affecting multiple organs. Central nervous system involvement is a common presentation. Tumor necrosis factor-alpha (TNF-alpha) is considered to play a major role in the disease pathogenesis. We describe a patient with a long history of neuro-Behçet's disease who showed a remarkable response to infliximab therapy. Given the variable and limited success of other interventions, the use of anti-TNF-alpha therapy seems to be effective for patients with refractory disease.

摘要

白塞病是一种影响多个器官的慢性复发性血管炎。中枢神经系统受累是常见表现。肿瘤坏死因子-α(TNF-α)被认为在该病发病机制中起主要作用。我们描述了一名有神经白塞病长期病史的患者,其对英夫利昔单抗治疗表现出显著反应。鉴于其他干预措施效果不一且有限,抗TNF-α治疗似乎对难治性疾病患者有效。

相似文献

1
Successful treatment of long-standing neuro-Behçet's disease with infliximab.英夫利昔单抗成功治疗长期神经白塞病。
J Rheumatol. 2005 Jan;32(1):181-3.
2
Treatment of neuro-Behçet's disease: an update.神经白塞病的治疗:最新进展
Expert Rev Neurother. 2009 Apr;9(4):565-74. doi: 10.1586/ern.09.11.
3
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.抗肿瘤坏死因子单克隆抗体治疗白塞病缓解:一例报告
BMC Musculoskelet Disord. 2003 Aug 28;4:19. doi: 10.1186/1471-2474-4-19.
4
Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.神经白塞病患者使用英夫利昔单抗治疗 2 年成功维持缓解。
J Dermatol. 2013 Aug;40(8):632-4. doi: 10.1111/1346-8138.12203. Epub 2013 Jun 3.
5
Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.抗TNF-α抗体英夫利昔单抗治疗难治性肠白塞病的疗效
Rheumatology (Oxford). 2009 Aug;48(8):1012-3. doi: 10.1093/rheumatology/kep126. Epub 2009 May 22.
6
Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.使用肿瘤坏死因子-α阻滞剂英夫利昔单抗成功治疗难治性白塞病。
Iran J Immunol. 2009 Mar;6(1):55-8.
7
Successful treatment of severe Behçet's disease with infliximab in an Italian Olympic athlete.英夫利昔单抗成功治疗一名意大利奥运运动员的严重白塞病。
J Rheumatol. 2008 May;35(5):930-2.
8
Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.英夫利昔单抗多次给药治疗难治性葡萄膜视网膜炎型白塞病的疗效、安全性及药代动力学
J Rheumatol. 2004 Jul;31(7):1362-8.
9
Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.七例白塞氏葡萄膜炎患者的抗TNF-α治疗:优势与争议点
Ann N Y Acad Sci. 2007 Sep;1110:474-84. doi: 10.1196/annals.1423.050.
10
A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade.一名神经白塞病患者用依那西普治疗成功:肿瘤坏死因子α阻断价值的进一步证据
Clin Neurol Neurosurg. 2007 Apr;109(3):279-81. doi: 10.1016/j.clineuro.2006.11.002. Epub 2006 Dec 14.

引用本文的文献

1
Effect of Infliximab on Chronic Progressive Neuro-Behçet's Disease: Influence of the Timing of Introduction on the Patient Outcome.英夫利昔单抗治疗慢性进展性神经白塞病的效果:引入时机对患者结局的影响。
Intern Med. 2024 Feb 15;63(4):481-486. doi: 10.2169/internalmedicine.1969-23. Epub 2023 Jun 21.
2
Infliximab is a plausible alternative for neurologic complications of Behçet disease.英夫利昔单抗是白塞病神经系统并发症的一种合理选择。
Neurol Neuroimmunol Neuroinflamm. 2016 Jul 8;3(5):e258. doi: 10.1212/NXI.0000000000000258. eCollection 2016 Oct.
3
Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study.
抗TNFα治疗重症难治性神经白塞病的疗效:一项观察性研究。
Medicine (Baltimore). 2016 Jun;95(23):e3550. doi: 10.1097/MD.0000000000003550.
4
Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome.用于神经白塞病的生物制剂、秋水仙碱、皮质类固醇、免疫抑制剂和α干扰素。
Cochrane Database Syst Rev. 2014;2014(12):CD010729. doi: 10.1002/14651858.CD010729.pub2. Epub 2014 Dec 18.
5
Behçet syndrome: from pathogenesis to novel therapies.白塞病:从发病机制到新疗法
Clin Exp Med. 2016 Feb;16(1):1-12. doi: 10.1007/s10238-014-0328-z. Epub 2014 Dec 2.
6
Update on the therapy of Behçet disease.白塞病治疗的最新进展。
Ther Adv Chronic Dis. 2014 May;5(3):112-34. doi: 10.1177/2040622314523062.
7
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.神经白塞病的诊断与管理:国际共识推荐
J Neurol. 2014 Sep;261(9):1662-76. doi: 10.1007/s00415-013-7209-3. Epub 2013 Dec 24.
8
Recent understanding on diagnosis and management of central nervous system vasculitis in children.儿童中枢神经系统血管炎诊断与管理的最新认识
Clin Dev Immunol. 2012;2012:698327. doi: 10.1155/2012/698327. Epub 2012 Sep 12.
9
Infliximab for patients with neuro-Behcet's disease: case series and literature review.英夫利昔单抗治疗神经白塞病患者:病例系列研究和文献复习。
Clin Rheumatol. 2011 Jul;30(7):1007-12. doi: 10.1007/s10067-011-1726-1. Epub 2011 Mar 24.
10
Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet's disease.对白塞病黏膜皮肤病变对抗 TNF-α 治疗反应迟滞。
Rheumatol Int. 2011 Aug;31(8):1097-9. doi: 10.1007/s00296-009-1276-x. Epub 2009 Dec 11.